Centella Mauritius Holdings Limited sold 6,24,00,000 equity shares of Aster DM Quality Care Limited , representing 7.16% of the total paid-up equity share capital, through an on-market transaction on August 19, 2026.

The disposal was disclosed under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition and Takeovers) Regulations, 2011. Centella Mauritius is not part of the promoter or promoter group of the target company.

Shareholding Changes

Prior to the sale, Centella Mauritius held 8,63,17,533 shares, accounting for 9.90% of the total voting capital. None of these shares were encumbered by pledge, lien, or non-disposal undertakings. The entity also held no warrants, convertible securities, or other instruments entitling it to receive shares carrying voting rights.

Following the transaction, the seller’s holding reduced to 2,39,17,533 shares, or 2.74% of the total paid-up equity share capital. The total diluted share/voting capital of Aster DM Quality Care remained unchanged at 87,16,72,439 equity shares.

What the Numbers Show

The sale represents a significant reduction in Centella Mauritius’s stake, with the entity offloading approximately 72% of its pre-transaction holding in a single open-market block. The remaining stake of 2.74% suggests a near-complete exit from a substantial position, reducing potential overhang concerns for other shareholders while indicating a decisive shift in the investor’s portfolio allocation.

Centella Mauritius Holdings Limited has disclosed a corrected shareholding of 9.90% in Aster DM Quality Care , revising previous reports that cited a 9.7% pledged stake. The disclosure, filed on August 20, 2026, clarifies discrepancies in automated system-driven filings regarding the post-merger equity structure.

The correction arises from the amalgamation of Quality Care India Limited (QCIL) into Aster DM Healthcare Limited. While an earlier disclosure on August 19, 2026, indicated a pledge of 84.4 million shares (9.7%), the updated filing reveals Centella’s total holding is 86,317,533 shares. This represents a significant upward revision in both absolute share count and percentage ownership.

Corrected Shareholding Structure

The new data supersedes the earlier pledge-centric view by detailing the total acquisition mechanics under the Scheme of Amalgamation sanctioned by the NCLT Hyderabad Bench on June 19, 2026. The share exchange ratio was fixed at 977 equity shares of Aster DM Quality Care for every 1,000 shares held in QCIL.

The pre-merger holding of 4,651,992 shares constituted 0.90% of the capital, not the 0.5% previously implied in some contexts relative to the expanded post-merger base. The merger added 81,665,541 shares, bringing the total paid-up equity capital to 871,672,439 shares of ₹10 each.

What the Numbers Show

The discrepancy between the initial 9.7% figure and the corrected 9.90% highlights the complexity of automated disclosures in large corporate actions. The initial report focused on pledged shares (84.4 million), likely reflecting a subset of the total holding or a specific encumbrance tranche. The corrected filing clarifies that Centella’s total voting rights stand at 86.3 million shares. This 0.2 percentage point difference, while seemingly small, represents over 1.8 million additional shares not captured in the initial pledge-focused narrative, underscoring the importance of verifying system-driven disclosures against manual regulatory filings under Regulation 29(1) of the Takeover Code.